Yangxin Pharmaceutical is located at No. 176 Hangzhou West Road, Huangshi City, within the Technology Business Incubator. It operates four subsidiaries, all collectively dedicated to providing * products and services for China's pharmaceutical science research sector. Yangxin Pharmaceutical is recognized as a * High-Tech Enterprise (GR202042001711), a Hubei Province Contract and Credit Honoring Enterprise, a Huangshi City Above-Scale Enterprise, and an enterprise supported by the Provincial Department of Science and Technology. It is also a key development unit supported by the Municipal Development and Reform Commission, the Economy and Information Technology Commission, and the Science and Technology Bureau. The company was listed on the Wuhan Equity Exchange's New Four Board in 2016, with equity code: S00903. Its products mainly include: drug reference standards, impurity reference materials, custom synthesis products, reference preparations, and more. It offers millions of products related to natural, biological, and chemical drugs, covering leading brands such as: CP, EP, USP, LGC, BP, JP, STD, TRC, TLC, etc. Currently, it serves over a thousand domestic corporate clients on a long-term basis, essentially covering China's top pharmaceutical companies, numerous listed companies, research institutes, CRO companies, and domestic universities. It has established a strong reputation in the industry and is a major supplier of reference materials. Additionally, it continuously exports products to the United States, Russia, Europe, Brazil, India, and more...